Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year

It’s unclear whether a deepening trade rift with the US could slow the stream of cash from China to medical innovation hubs such as Silicon Valley and Cambridge, Massachusetts

Chinese investors are pumping money into US drug start-ups as Beijing seeks to become a global leader in new medicines, adding to a flood of cash flowing to groundbreaking health firms. Read more